I cell disease - ορισμός. Τι είναι το I cell disease
Diclib.com
Λεξικό ChatGPT
Εισάγετε μια λέξη ή φράση σε οποιαδήποτε γλώσσα 👆
Γλώσσα:

Μετάφραση και ανάλυση λέξεων από την τεχνητή νοημοσύνη ChatGPT

Σε αυτήν τη σελίδα μπορείτε να λάβετε μια λεπτομερή ανάλυση μιας λέξης ή μιας φράσης, η οποία δημιουργήθηκε χρησιμοποιώντας το ChatGPT, την καλύτερη τεχνολογία τεχνητής νοημοσύνης μέχρι σήμερα:

  • πώς χρησιμοποιείται η λέξη
  • συχνότητα χρήσης
  • χρησιμοποιείται πιο συχνά στον προφορικό ή γραπτό λόγο
  • επιλογές μετάφρασης λέξεων
  • παραδείγματα χρήσης (πολλές φράσεις με μετάφραση)
  • ετυμολογία

Τι (ποιος) είναι I cell disease - ορισμός

HUMAN DISEASE
Mucolipidosis II; Inclusion-cell disease; Inclusion cell disease; Inclusion-Cell Disease; Mucolipidosis Ii; ML II; I cell disease; I Cell disease; I Cell Disease

I-cell disease         
Inclusion-cell (I-cell) disease, also referred to as mucolipidosis II (ML II), is part of the lysosomal storage disease family and results from a defective phosphotransferase (an enzyme of the Golgi apparatus). This enzyme transfers phosphate to mannose residues on specific proteins.
Sickle Cell Anemia, a Molecular Disease         
SCIENTIFIC ARTICLE
User:Ragesoss/Sickle Cell Anemia, a Molecular Disease
"Sickle Cell Anemia, a Molecular Disease" is a 1949 scientific paper by Linus Pauling, Harvey A. Itano, Seymour J.
Glycogen storage disease type I         
  • Map of effects in GSDIa from non-functioning glucose-6-phosphatase.
  • Hepatomegaly with enlarged liver visible in red crosshairs and extending downward.
RARE DISEASE
Von Gierke's Disease; Von Gierke disease; Glucose-6-phosphatase deficiency; Von Gierke's disease; GSD type I; Glycogen storage disease type 1B; Glycogen storage disease type i; Gierke's disease; Von Gierke Disease; GSD I; Hepato-renal glycogenesis; Glerke's disease; Glycogen storage disease type 1b; Glycogen storage disease type 1C; Type 1 glycogen storage disease; Von gierke; Von gierke disease; Von Gierke's syndrome
Glycogen storage disease type I (GSD I) is an inherited disease that results in the liver being unable to properly break down stored glycogen. This impairment disrupts the liver's ability to break down stored glycogen that is necessary to maintain adequate blood sugar levels.

Βικιπαίδεια

I-cell disease

Inclusion-cell (I-cell) disease, also referred to as mucolipidosis II (ML II), is part of the lysosomal storage disease family and results from a defective phosphotransferase (an enzyme of the Golgi apparatus). This enzyme transfers phosphate to mannose residues on specific proteins. Mannose-6-phosphate serves as a marker for proteins to be targeted to lysosomes within the cell. Without this marker, proteins are instead secreted outside the cell, which is the default pathway for proteins moving through the Golgi apparatus. Lysosomes cannot function without these proteins, which function as catabolic enzymes for the normal breakdown of substances (e.g. oligosaccharides, lipids, and glycosaminoglycans) in various tissues throughout the body (i.e. fibroblasts). As a result, a buildup of these substances occurs within lysosomes because they cannot be degraded, resulting in the characteristic I-cells, or "inclusion cells" seen microscopically. In addition, the defective lysosomal enzymes normally found only within lysosomes are instead found in high concentrations in the blood, but they remain inactive at blood pH (around 7.4) because they require the low lysosomal pH 5 to function.